NutriBand (NTRB) Capital Expenditures (2021 - 2025)
NutriBand's (NTRB) quarterly Capital Expenditures came in at $5324.0 in Q2 2025, down 14.06% year-on-year from $6195.0 in Q2 2024, and down 88.66% quarter-over-quarter from $46958.0 in Q4 2024.
NutriBand (NTRB) Capital Expenditures (2021 - 2025) Analysis & Trends
NutriBand has disclosed Capital Expenditures across 5 years of filings, most recently posting $5324.0 for Q2 2025.
- Capital Expenditures for Q2 2025 came in at $5324.0, down 14.06% year-over-year; the trailing twelve-month figure through Jan 2026 was $5324.0 (down 94.22% YoY), and the FY2026 annual result was $5324.0, down 94.22% from the prior year.
- Capital Expenditures came in at $5324.0 for Q2 2025 at NutriBand, down from $46958.0 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $49137.0 in Q1 2024 to a low of $1272.0 in Q4 2022.
- The 5-year median for Capital Expenditures is $17411.5 (2021), against an average of $22144.8.
- Across the five-year window, Capital Expenditures slumped 94.01% in 2023 and soared 390.24% in 2024, its largest moves.
- NutriBand's Capital Expenditures stood at $1992.0 in 2021, then tumbled by 36.14% to $1272.0 in 2022, then jumped by 106.29% to $2624.0 in 2023, then soared by 1689.56% to $46958.0 in 2024, then slumped by 88.66% to $5324.0 in 2025.
- The last three Capital Expenditures figures came in at $5324.0 (Q2 2025), $46958.0 (Q4 2024), and $38890.0 (Q3 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 133.40 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -63,220.27 |
| 10 | NutriBand | 41.91 Mn | 37.33 Mn | 88,941.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2025 | 5,324.00 |
| Apr 30, 2025 | 5,324.00 |
| Oct 31, 2024 | 46,958.00 |
| Oct 31, 2024 | 46,958.00 |
| Jul 31, 2024 | 38,890.00 |
| Jul 31, 2024 | 38,890.00 |
| Apr 30, 2024 | 6,195.00 |
| Apr 30, 2024 | 6,195.00 |
| Jan 31, 2024 | 49,137.00 |
| Jan 31, 2024 | 49,137.00 |
| Apr 30, 2023 | 2,624.00 |
| Apr 30, 2023 | 2,624.00 |
| Jan 31, 2023 | 10,023.00 |
| Jan 31, 2023 | 10,023.00 |
| Oct 31, 2022 | 1,272.00 |
| Oct 31, 2022 | 1,272.00 |
| Jul 31, 2022 | 24,206.00 |
| Jul 31, 2022 | 24,206.00 |
| Apr 30, 2022 | 43,803.00 |
| Apr 30, 2022 | 43,803.00 |